SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

17 hedge funds and large institutions have $560K invested in Scinai Immunotherapeutics in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

37% less capital invested

Capital invested by funds: $891K → $560K (-$331K)

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$49K
2
+$40K
3
+$26.2K
4
HF
HRT Financial
New York
+$7.23K
5
UBS Group
UBS Group
Switzerland
+$2.44K

Top Sellers

1
-$259K
2
-$33K
3
-$14K
4
Morgan Stanley
Morgan Stanley
New York
-$13.4K
5
State Street
State Street
Massachusetts
-$1.54K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$175K
2
$100K
3
$78K
4
$59K
5
$49K
6
$40K
7
$30K
8
$9K
9
$6K
10
$6K
11
$3K
12
$2K
13
$1K
14
$1K
15
$1K
16
–
17
–
18
–